CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Neutral
AI Analysis

Summary

Nektar Therapeutics announced inducement grants of non-qualified stock options to purchase 58,600 shares approved by its Board Compensation Committee on September 18, 2026.

Importance:2/10
Sentiment:
0.00
inducement grantsstock optionsnasdaq rule 5635compensation
Related Companies

Read the original article

Published by PR Newswire Biotech on September 25, 2026 8:15 PM

Read Original